# Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma

Source: https://onco.cc/trials/nct01011231/  
OnCo record `nct01011231` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Gamma Knife in Glioma & glioblastoma, run by University of California, San Francisco, recorded as terminated on the registry.

## Summary

Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma is a phase 2 interventional study registered as NCT01011231 by University of California, San Francisco, with 1 participants recorded, started 2009-12 and due to reach its primary completion in 2011-04. Interventions recorded: Gamma Knife Radiosurgery. Conditions recorded: Glioblastoma.

Linked to the technology Gamma Knife because the registry names it ("gamma knife") among its interventions and Glioma & glioblastoma among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT01011231
- Phase: 2
- Setting: Phase II Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Spectroscopy for Target Definition in Patients With Recurrent Glioma
- Sponsor: University of California, San Francisco
- Enrolled: 1

## Sources

- ClinicalTrials.gov NCT01011231: https://clinicaltrials.gov/study/NCT01011231

## Connected records

- cancers: [Glioma & glioblastoma](https://onco.cc/cancers/glioblastoma/)
- technologies: [Gamma Knife](https://onco.cc/technologies/gamma-knife/)

---
JSON: https://onco.cc/api/v1/entities/nct01011231.json